Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)

BACKGROUND AND AIMS: Currently, less than 20% of patients at very high-risk achieve ESC/EAS dyslipidemia guideline-recommended LDL-C target levels in Europe. “Jena auf Ziel—JaZ” is a prospective cohort study in which early combination therapy with atorvastatin 80 mg and ezetimibe 10 mg was initiated...

Descripción completa

Detalles Bibliográficos
Autores principales: Makhmudova, Umidakhon, Samadifar, Beasat, Maloku, Aurel, Haxhikadrija, Pellumb, Geiling, Jens-Arndt, Römer, Robert, Lauer, Bernward, Möbius-Winkler, Sven, Otto, Sylvia, Schulze, P. Christian, Weingärtner, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449699/
https://www.ncbi.nlm.nih.gov/pubmed/36602598
http://dx.doi.org/10.1007/s00392-022-02147-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449699/
https://www.ncbi.nlm.nih.gov/pubmed/36602598
http://dx.doi.org/10.1007/s00392-022-02147-3

Ejemplares similares